Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$8.5M
+124.9% from 2023
Prescriptions
54K
$156.26 per claim
Patients
29K
22,250 prescribers
Total spending, 2024
$8.5M
$287.67 per patient
Medicare prescription drug plans paid $8.5M for Insulin Degludec Pen (U-100) in 2024, for 54,250 prescriptions and refills to 29,466 patients (up 124.9% from 2023). The average cost per claim was $156.26.
Texas had the highest Medicare cost for Insulin Degludec Pen (U-100) in 2024: $901K for 5,297 claims, followed by Florida ($621K).
Janet Martinez, nurse practitioner in Miami, FL, had the highest Medicare cost for Insulin Degludec Pen (U-100) in 2024: 317 claims costing $36K.
Insulin Degludec Pen (U-100) is made by Novo Nordisk A/S (NVO), listed in the Medicare spending data as Novo Nordisk.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Janet Martinez Miami, FL | Nurse Practitioner | 317 | 166 | $36K |
| Daniela M Dicenso Miami, FL | Internal Medicine | 183 | 49 | $29K |
| Valentina Salvat Garcia |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 773 | 1,174 | 806 | $144K |
| 2023 | 10,699 | 24,014 | 12,361 | $3.8M |
| 2024 | 22,250 | 54,250 | 29,466 | $8.5M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Nurse Practitioner |
| 158 |
| 57 |
| $17K |
| Chadi Richeh Rancho Mirage, CA | Endocrinology | 44 | 32 | $13K |
| Silvia M Cuadra Mongalo Port Orange, FL | Endocrinology | 71 | 22 | $13K |
| Daile Grave de Peralta Miami, FL | Internal Medicine | 177 | 65 | $13K |
| Antonio Marrero Miami, FL | Nurse Practitioner | 104 | 26 | $11K |
| Gerald Miceli Ormond Beach, FL | Endocrinology | 87 | 25 | $11K |
| Janet H Durham Nathalie, VA | Nurse Practitioner | 46 | 14 | $8,835 |
| Adriana Meza Chula Vista, CA | Nurse Practitioner | 91 | Under 11 | $8,709 |
| Mohammad T Ijaz Zanesville, OH | Endocrinology | 21 | 15 | $8,052 |
| Vladimir K Bakalov Orange City, FL | Endocrinology | 37 | 12 | $8,012 |
| Tonya I Koopman Bend, OR | Nurse Practitioner | 41 | 19 | $6,721 |
| Mary L Smock Macon, GA | Nurse Practitioner | 21 | Under 11 | $6,628 |
| Adriana G Celiz Chula Vista, CA | Nurse Practitioner | 33 | Under 11 | $6,464 |
| Michael A Ahearn Kewanee, IL | Hospitalist | 76 | 23 | $6,374 |
| Irina A Urusova Los Angeles, CA | Endocrinology | 37 | 13 | $6,344 |
| Hazel Yang Ashland, KY | Endocrinology | 15 | Under 11 | $6,274 |
| Tamara J Stull Colorado Springs, CO | Nurse Practitioner | 44 | Under 11 | $6,024 |
| Patricia J Redhage Heavener, OK | Nurse Practitioner | 22 | Under 11 | $5,986 |
| K. G Thampy Saint Louis, MO | Endocrinology | 30 | Under 11 | $5,831 |
| Seong-Hye Kim Gastonia, NC | Nurse Practitioner | 43 | Under 11 | $5,486 |
| Corey D Finch Sr. Oklahoma City, OK | Emergency Medicine | 34 | 14 | $5,456 |
| Matthew Loudon Wasilla, AK | Physician Assistant | 18 | 11 | $5,426 |
| Kristyl J Woolsey Little Rock, AR | Nurse Practitioner | 18 | 13 | $5,395 |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novo Nordisk NVO | 54,277 | $8.5M |